Immobilized human IL-17A at 0.5 μg/ml (50 μL/well) can bind to Ixekizumab with a linear range of 1.221 ng/ml-5 μg/ml.
Anti-IL-17A Monoclonal Antibody(Ixekizumab)
Anti-IL-17A Monoclonal Antibody(Ixekizumab)
Price:
Regular price
$285 USD
Regular price
Sale price
$285 USD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Human |
| Antigen | IL-17A |
| Synonyms | Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8 (CTLA-8), CTLA8, IL17 |
| Accession | Q16552 |
| Clone Number | S-SC008 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG4,k |
| Application | Blocking of IL-17A signaling Functional assays |
| Purification | Protein A |
| Concentration | 2 mg/ml |
| Endotoxin | <1EU/mg |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4, containing no preservative |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| ELISA | 1.221-5000 ng/ml |
Background
Ixekizumab is an injectable medication for the treatment of autoimmune diseases. It is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.
Picture
Picture
ELISA
